Novel application of multicellular layers culture for in situ evaluation of cytotoxicity and penetration of paclitaxel

Cancer Science

Volumn 99, Issue 2, 2008, Pages 423-431

  Al Abd, Ahmed Mohamed ^a   Lee, Joo Ho ^a   Kim, So Yeon ^b   Kun, Na ^a   Kuh, Hyo Jeong ^a  

^a The Catholic University of Korea   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CALCEIN; PACLITAXEL; RHODAMINE;

ANALYTIC METHOD; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL STRAIN HT29; CELL VIABILITY; COLORECTAL CANCER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG EXPOSURE; DRUG PENETRATION; DRUG SCREENING; FLUORESCENCE ANALYSIS; FROZEN SECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL PROLIFERATION; CELL SURVIVAL; CULTURE TECHNIQUES; DRUG EVALUATION, PRECLINICAL; FLUORESCEINS; FLUORESCENT DYES; HUMANS; MICROSCOPY, CONFOCAL; NEOPLASMS; PACLITAXEL; TUMOR CELLS, CULTURED;

EID: 38949173868     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00700.x     Document Type: Article

References (37)

1. Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer 2006; 6: 583-92.
2. Tannock IF, Lee CM, Tunggal JK, Cowan DS, Egorin MJ. Limited penetration of anticancer drugs through tumor tissue: A potential cause of resistance of solid tumors to chemotherapy. Clin Cancer Res 2002; 8: 878-84.
3. Tunggal JK, Cowan DS, Shaikh H, Tannock IF. Penetration of anticancer drugs through solid tissue: A factor that limits the effectiveness of chemotherapy for solid tumors. Clin Cancer Res 1999; 5: 1583-6.
4. Zheng JH, Chen CT, Au JL, Wientjes MG. Time- and concentration-dependent penetration of doxorubicin in prostate tumors. AAPS Pharmsci 2001; 3: E15.
5. Hicks KO, Pruijn FB, Baguley BC, Wilson WR. Extravascular transport of the DNA intercalator and topoisomerase poison N-[2-(Dimethylamino) ethyl]acridine-4-carboxamide (DACA): Diffusion and metabolism in multicellular layers of tumor cells. J Pharmacol Exp Ther 2001; 297: 1088-98.
6. Jang SH, Wientjes MG, Au JL. Determinants of paclitaxel uptake, accumulation and retention in solid tumors. Invest New Drugs 2001; 19: 113-23.
7. Nicholson KM, Bibby MC, Phillips RM. Influence of drug exposure parameters on the activity of paclitaxel in multicellular spheroids. Eur J Cancer 1997; 33: 1291-8.
8. Desoize B. Contribution of three-dimensional culture to cancer research. Crit Rev Oncol Hematol 2000; 36: 59-60.
9. Santini MT, Rainaldi G, Indovina PL. Apoptosis, cell adhesion and the extracellular matrix in the three-dimensional growth of multicellular tumor spheroids. Crit Rev Oncol Hematol 2000; 36: 75-87.
10. Bates RC, Edwards NS, Yates JD. Spheroids and cell survival. Crit Rev Oncol Hematol 2000; 36: 61-74.
11. Baguley BC, Marshall ES. In vitro modelling of human tumour behaviour in drug discovery programmes. Eur J Cancer 2004; 40: 794-801.
12. Phillips RM, Loadman PM, Cronin BP. Evaluation of a novel in vitro assay for assessing drug penetration into avascular regions of tumours. Br J Cancer 1998; 77: 2112-19.
13. Kyle AH, Huxham LA, Chiam AS, Sim DH, Minchinton AI. Direct assessment of drug penetration into tissue using a novel application of three-dimensional cell culture. Cancer Res 2004; 64: 6304-9.
14. Cowan DS, Hicks KO, Wilson WR. Multicellular membranes as an in vitro model for extravascular diffusion in tumours. Br J Cancer Suppl 1996; 27: S28-31.
15. Hicks KO, Pruijn FB, Sturman JR, Denny WA, Wilson WR. Multicellular resistance to tirapazamine is due to restricted extravascular transport: a pharmacokinetic/pharmacodynamic study in HT29 multicellular layer cultures. Cancer Res 2003; 63: 5970-7.
16. AL-Abd AM, Lee JH, Kuh HJ. Simultaneous evaluation of cellular vitality and drug penetration in multicellular layers of human cancer cells. J Korean Pharmaceut Sci 2006; 36: 309-14.
17. Lee SH, AL-Abd AM, Park JK, Cha JH, Kuh HJ. Pharmacodynamics of CKD-602 (Belotecan) in 3D cultures of human colorectal carcinoma cells. J Appl Pharmacol 2006; 14: 119-24.
18. Hall MD, Martin C, Ferguson DJ, Phillips RM, Hambley TW, Callaghan R. Comparative efficacy of novel platinum (IV) compounds with established chemotherapeutic drugs in solid tumour models. Biochem Pharmacol 2004; 67: 17-30.
19. Frankel A, Buckman R, Kerbel RS. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids. Cancer Res 1997; 57: 2388-93.
20. Wartenberg M, Acker H. Quantitative recording of vitality patterns in living multicellular spheroids by confocal microscopy. Micron 1995; 26: 395-404.
21. Wartenberg M, Hescheler J, Acker H, Diedershagen H, Sauer H. Doxorubicin distribution in multicellular prostate cancer spheroids evaluated by confocal laser scanning microscopy and the 'optical probe technique'. Cytometry 1998; 31: 137-45.
22. Rowinsky EK. Clinical pharmacology of Taxol. J Natl Cancer Inst Monogr 1993; 15: 25-37.
23. Kuh HJ, Jang SH, Wientjes MG, Weaver JR, Au JL. Determinants of paclitaxel penetration and accumulation in human solid tumor. J Pharmacol Exp Ther 1999; 290: 871-80.
24. Martin C, Walker J, Rothnie A, Callaghan R. The expression of P-glycoprotein does influence the distribution of novel fluorescent compounds in solid tumour models. Br J Cancer 2003; 89: 1581-9.
25. Kuh HJ, Jang SH, Wientjes MG, Au JL. Computational model of intracellular pharmacokinetics of paclitaxel. J Pharmacol Exp Ther 2000; 293: 761-70.
26. Jang SH, Wientjes MG, Au JL. Interdependent effect of P-glycoprotein-mediated drug efflux and intracellular drug binding on intracellular paclitaxel pharmacokinetics: Application of computational modeling. J Pharmacol Exp Ther 2003; 304: 773-80.
27. Swanton C, Tomlinson I, Downward J. Chromosomal instability, colorectal cancer and taxane resistance. Cell Cycle 2006; 5: 818-23.
28. Evangelio JA, Abal M, Barasoain I et al. Fluorescent taxoids as probes of the microtubule cytoskeleton. Cell Motil Cytoskeleton 1998; 39: 73-90.
29. Yazawa K, Tsuno NH, Kitayama J et al. Selective inhibition of cyclooxygenase-2 inhibits colon cancer cell adhesion to extracellular matrix by decreased expression of beta1 integrin. Cancer Sci 2005;96: 93-9.
30. Lu D, Wientjes MG, Lu Z, Au JL. Tumor priming enhances delivery and efficacy of nanomedicines. J Pharmacol Exp Ther 2007; 322: 80-8.
31. Modok S, Hyde P, Mellor HR, Roose T, Callaghan R. Diffusivity and distribution of vinblastine in three-dimensional tumour tissue: experimental and mathematical modelling. Eur J Cancer 2006; 42: 2404-13.
32. Guy R, Scott Z, Sloboda R, Nicolaou K. Fluorescent taxoids. Chem Biol 1996; 3: 1021-31.
33. Baloglu E, Kingston DG, Patel P, Chatterjee SK, Bane SL. Synthesis and microtubule binding of fluorescent paclitaxel derivatives. Bioorg Med Chem Lett 2001; 11: 2249-52.
34. Grantab R, Sivananthan S, Tannock IF. The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. Cancer Res 2006; 66: 1033-9.
35. Lee CM, Tannock IF. Inhibition of endosomal sequestration of basic anticancer drugs: Influence on cytotoxicity and tissue penetration. Br J Cancer 2006; 94: 863-9.
36. Cowan DS, Tannock IF. Factors that influence the penetration of methotrexate through solid tissue. Int J Cancer 2001; 91: 120-5.
37. Tunggal JK, Ballinger JR, Tannock IF. Influence of cell concentration in limiting the therapeutic benefit of P-glycoprotein reversal agents. Int J Cancer 1999; 81: 741-7.